Invest. Support. Grow.

In a monumental industry like healthcare, transformation requires dedication, financial investment and real manpower. We invest in innovative companies and provide the resources to help our partners grow and change the future of healthcare.

About Nueterra Capital

Nueterra Capital was founded to empower entrepreneurs — to equip innovative minds with the capital, resources and expertise to help drive change in the healthcare industry.

Learn More

Sickweather knows where sick people are and where they will be up to 15 weeks in advance. Their patented social listening technology detects illness trends in real-time at a hyper local level, in over 120 countries. That data is then modeled into 15-week forecasts and a threat level index call the SickScore. Sickweather recently introduced the COVID-19 Score, indicating the risk factor for illness in a particular city. Users can research the risk for their own locations, as well as those of their friends and families. They can also report COVID-19 cases within the app itself.

View Our Full Portfolio

Portfolio Spotlight

Sickweather | A Nueterra Capital Portfolio Company
Logo for IVX Health, a Nueterra Capital portfolio company

IVX Health Opens Three New Infusion Centers in Indianapolis

The new facilities in Emerson Pointe, Fishers Corner, and Park Meridian follow on the company's recent Chicagoland expansion.
Read More
Moving Analytics | A Nueterra Capital Portfolio Company

Moving Analytics Co-Founder Ade Adesanya Named to Pitchbook’s “Black Founders and Investors to Watch” List

Moving Analytics is the leading platform for delivering virtual cardiovascular rehabilitation programs.
Read More
Moving Analytics | A Nueterra Capital Portfolio Company

Omada Health President Adrian James Joins Moving Analytics’ Board of Directors

The strategic addition positions the company to take advantage of rapid growth buoyed by interest in telehealth services.
Read More

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from Nueterra Capital.

You have Successfully Subscribed!